Hims Stock Rockets On Novo Nordisk Partnership After FDA Weight-Loss Drug Ruling Crashes Shares

investors.com/stock-lists/ibd-50/hims-stock-fda-weight-loss-drugs/?src=A00220

Hims & Hers Health (HIMS) has risen amid some swift navigation around recent rulings involving obesity drugs from the Food and Drug Administration. It's one reason why Hims & Hers Health stock holds first place in the elite IBD 50 list of growth stocks from Investor's Business Daily. The…

This story appeared on investors.com, 2025-05-16 17:26:51.
The Entire Business World on a Single Page. Free to Use →